Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
PharmaEssentia Invests $46M to Expand U.S. Manufacturing Footprint for BESREMi®
PharmaEssentia Corporation has announced plans to establish a new wholly owned manufacturing subsidiary in Puerto Rico The US$46 million investment aims to expand the production of BESREMi
Novartis Expands R&D Capacity with $23B San Diego Investment
Novartis has begun construction on a new global Biomedical Research centre in San Diego, California, as part of a USD 23 billion investment in US research and development and advanced manufacturing
Vetter Pharma Plans State-of-the-Art €480M Production Facility in Germany
Vetter Pharma, a leading global pharmaceutical service provider specialising in injectable drugs, has announced plans to build a new stateoftheart production facility in Saarlouis, Saarland, southwest Germany
BD Invests $110 Million to Expand U.S. Biologic Drug Supply Chain
BD Becton, Dickinson and Company is investing $110 million to expand production of prefillable syringes at its Columbus, Nebraska site The investment aims to strengthen the US pharmaceutical supply chain, support reshoring of drug manufacturing
Sharp Services Invests Over €20 Million to Expand European Injectable Packaging
Sharp Services has announced a major investment of more than 20 million to expand its European facilities for injectable drug packaging The move responds to growing demand for complex injectable formats and aims to increase production
Samsung Biologics Expands U.S. Manufacturing with $280 Million Acquisition of Human Genome Sciences
Samsung Biologics has announced the acquisition of Human Genome Sciences from GSK, marking its first USbased manufacturing site The Rockville, Maryland facility will expand the companys global manufacturing
INCOG BioPharma Plans Major $200 Million Facility Expansion in Indiana
INCOG BioPharma Services has announced a major $200 million expansion of its injectable drug manufacturing facility in Fishers, Indiana The investment will significantly increase production capacity and support longterm growth, positioning the site as a leading global hub for injectable biopharmaceutical manufacturing
AstraZeneca Expands U.S. Manufacturing Capacity with $2B Maryland Investment
AstraZeneca has announced plans to invest $2 Billion in expanding its manufacturing operations in Maryland, strengthening its presence in one of the United States leading life sciences regions
Moderna Expands U.S. Manufacturing Capabilities with $140M Investment
Moderna, Inc is expanding its US manufacturing capabilities by onshoring Drug Product production to its Moderna Technology Center MTC in Norwood, Massachusetts This development completes the companys
Eli Lilly to Expand European Footprint with $3B Oral Medicines Plant in Netherlands
Eli Lilly and Company plans to invest $3 billion in a new manufacturing facility in Katwijk, located within the Leiden Bio Science Park in the Netherlands
